1. A novel Bcr-Abl–mTOR–eIF4A axis regulates IRES-mediated translation of LEF-1. Issue 11 (November 2014) Authors: Tsai, Becky Pinjou; Jimenez, Judith; Lim, Sharon; Fitzgerald, Kerry D.; Zhang, Min; Chuah, Charles T. H.; Axelrod, Haley; Nelson, Luke; Ong, S. Tiong; Semler, Bert L.; Waterman, Marian L. Journal: Open biology Issue: Volume 4:Issue 11(2014) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. BIM deletion polymorphism profiling complements prognostic values of risk scores in imatinib-treated Asian chronic myeloid leukemia patients. Issue 1 (2nd January 2019) Authors: Than, Hein; Lye, Weng K.; Sng, Colin; Allen, John C.; Ong, S. Tiong; Chuah, Charles Journal: Leukemia & lymphoma Issue: Volume 60:Issue 1(2019) Page Start: 234 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Phase I study of vorinostat with gefitinib in BIM deletion polymorphism/epidermal growth factor receptor mutation double‐positive lung cancer. Issue 2 (6th January 2020) Authors: Takeuchi, Shinji; Hase, Tetsunari; Shimizu, Shinobu; Ando, Masahiko; Hata, Akito; Murakami, Haruyasu; Kawakami, Takahiro; Nagase, Katsuhiko; Yoshimura, Kenichi; Fujiwara, Tadami; Tanimoto, Azusa; Nishiyama, Akihiro; Arai, Sachiko; Fukuda, Koji; Katakami, Nobuyuki; Takahashi, Toshiaki; Hasegawa, Y... Journal: Cancer science Issue: Volume 111:Issue 2(2020) Page Start: 561 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗